| 注册
首页|期刊导航|肿瘤药学|艾迪注射液联合TC方案治疗晚期上皮性卵巢癌的临床疗效分析

艾迪注射液联合TC方案治疗晚期上皮性卵巢癌的临床疗效分析

钟荣钟 肖文辉 林洁 何凌

肿瘤药学Issue(5):366-369,4.
肿瘤药学Issue(5):366-369,4.DOI:10.3969/j.issn.2095-1264.2014.075

艾迪注射液联合TC方案治疗晚期上皮性卵巢癌的临床疗效分析

Analysis of the Clinical Effects of Aidi Injection Combined with TC Regimen on Advanced Epithelial Ovarian Cancer

钟荣钟 1肖文辉 1林洁 1何凌2

作者信息

  • 1. 邵阳县妇幼保健院,湖南 邵阳,422100
  • 2. 中南大学湘雅二医院妇产科,湖南 长沙,410008
  • 折叠

摘要

Abstract

Objective To explore the clinical efficacy and safety of advanced epithelial ovarian cancer treated by Aidi in-jection combined with TC Regimen. Methods 52 patients with advanced epithelial ovarian cancer were divided randomly into the treatment group (n=26) and the control group (n=26). The treatment group was treated with Aidi injection and TC regimen;while the control group was only applied to TC regimen. Comparing the clinical effects and safety according to total effect rate, KPS grade as well as toxic and side effects. Results The total effective rate and the KPS improvement rate of the treatment group both were higher than those of the control group, and the differences were statistically significant(P<0.05). The differ-ence of adverse reactions between the two group had no statistical significance(P>0.05). Conclusion The way of Aidi injection combined with TC regimen had good clinical effect on advanced epithelial ovarian cancer, and was a safe regimen in clinic.

关键词

艾迪注射液/TC方案/上皮性卵巢癌/临床疗效

Key words

Aidi injection/TC Regimen/Advanced epithelial ovarian cancer/Clinical efficacy

分类

医药卫生

引用本文复制引用

钟荣钟,肖文辉,林洁,何凌..艾迪注射液联合TC方案治疗晚期上皮性卵巢癌的临床疗效分析[J].肿瘤药学,2014,(5):366-369,4.

肿瘤药学

2095-1264

访问量0
|
下载量0
段落导航相关论文